Clinical Trials Directory

Trials / Unknown

UnknownNCT05624177

Colonisation Efficacy of a Probiotic Chewing Gum.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
BLIS Technologies Limited · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

To evaluate the colonization efficacy (the ability of a probiotic bacteria to remain in the mouth) delivered in a chewing gum format. The chewing gum contains Streptococcus salivarius probiotic and the study is to be done in health adults.

Detailed description

This is a single blind, randomized controlled study to evaluate the colonization effectiveness of a chewing gum containing a commercially available probiotic bacterium. Participants will be randomly assigned to one of the two groups consuming chewing gum containing Streptococcus salivarius M18 over a 7-day period. Saliva samples will be collected at pre determined points (pre and post intervention). Colonization efficacy will be determined by enumerating the probiotic from the saliva samples using standard microbiological techniques.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTStreptococcus salivarius M18 probiotic 1 billion colony forming units chewing gum (chew 5 minutes)Probiotic Streptococcus salivarius M18 products are commercially available in traditional formats such as a chewable tablet (lozenge) for local delivery to the oral cavity to provide health benefits. In this study, a chewing gum formulation will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.
DIETARY_SUPPLEMENTStreptococcus salivarius M18 probiotic 1 billion colony forming units chewing gum (chew 10 minutes)Probiotic Streptococcus salivarius M18 products are commercially available in traditional formats such as a chewable tablet (lozenge) for local delivery to the oral cavity to provide health benefits. In this study, a chewing gum formulation will be evaluated for its potential of delivering probiotic Streptococcus salivarius M18 to the oral cavity.

Timeline

Start date
2022-12-01
Primary completion
2023-01-01
Completion
2023-03-01
First posted
2022-11-22
Last updated
2022-11-23

Locations

1 site across 1 country: New Zealand

Source: ClinicalTrials.gov record NCT05624177. Inclusion in this directory is not an endorsement.